Yang Lv
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yang Lv has a total of 135 co-authors. Here are the top co-authors by number of shared publications:
Yuan Cao
21 shared publicationsZengzhen Cui
18 shared publications- Fang Zhou
Department of Orthopedics Peking University Third Hospital Beijing China
12 shared publications Jixing Fan
Department of Orthopedics, Peking University Third Hospital, Beijing, China
11 shared publicationsShan Gao
10 shared publicationsFang Zhou
8 shared publications
Latest Publications
- Open Access
- 13 November 2026
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
Management of hook-negative/external rotation stress-positive syndesmotic injuries in supination-external rotation type IV ankle fractures: a comparison of suture button, screw fixation, and non-fixation
- 13 November 2026
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
Open AccessManagement of hook-negative/external rotation stress-positive syndesmotic injuries in supination-external rotation type IV ankle fractures: a comparison of suture button, screw fixation, and non-fixation
- Open Access
- 8 September 2026
- Published by Wiley in Advanced Science
- p. e77649
Gut Microbiota‐Derived Indole‐3‐Propionic Acid Alleviates Diabetic Osteoporosis Through Nrf2‐Mediated Ferroptosis Suppression
Diabetic osteoporosis combines impaired bone formation with disproportionate skeletal fragility, yet the microbial metabolites linking diabetes‐associated dysbiosis to bone dysfunction remain unclear. This study implicates indole‐3‐propionic acid (IPA), a gut microbiota‐derived tryptophan metabolite, in the maintenance of skeletal homeostasis under diabetic conditions. Circulating IPA was lower in diabetic mice and in a small exploratory cohort of patients with diabetic osteoporosis. IPA concentrations were positively associated with bone mass. Metagenomic profiling linked lower IPA to impaired microbial tryptophan metabolism and reduced Clostridium abundance. In diabetic mice, IPA supplementation improved trabecular microarchitecture and bone formation. In bone marrow mesenchymal stem cells subjected to high glucose and palmitate, IPA also restored GPX4 and SLC7A11 expression and was associated with recovery of Nrf2‐mediated antioxidant signaling. Pharmacological inhibition of Nrf2 substantially attenuated these anti‐ferroptosis and pro‐osteogenic effects. Together, these findings support a gut microbiota‐IPA‐Nrf2‐ferroptosis pathway linking altered microbial tryptophan metabolism to impaired osteogenesis. They provide a rationale for evaluating IPA as a potential therapeutic strategy for diabetic osteoporosis.
- 8 September 2026
- Published by Wiley in Advanced Science
- p. e77649
Open AccessGut Microbiota‐Derived Indole‐3‐Propionic Acid Alleviates Diabetic Osteoporosis Through Nrf2‐Mediated Ferroptosis Suppression
Diabetic osteoporosis combines impaired bone formation with disproportionate skeletal fragility, yet the microbial metabolites linking diabetes‐associated dysbiosis to bone dysfunction remain unclear. This study implicates indole‐3‐propionic acid (IPA), a gut microbiota‐derived tryptophan metabolite, in the maintenance of skeletal homeostasis under diabetic conditions. Circulating IPA was lower in diabetic mice and in a small exploratory cohort of patients with diabetic osteoporosis. IPA concentrations were positively associated with bone mass. Metagenomic profiling linked lower IPA to impaired microbial tryptophan metabolism and reduced Clostridium abundance. In diabetic mice, IPA supplementation improved trabecular microarchitecture and bone formation. In bone marrow mesenchymal stem cells subjected to high glucose and palmitate, IPA also restored GPX4 and SLC7A11 expression and was associated with recovery of Nrf2‐mediated antioxidant signaling. Pharmacological inhibition of Nrf2 substantially attenuated these anti‐ferroptosis and pro‐osteogenic effects. Together, these findings support a gut microbiota‐IPA‐Nrf2‐ferroptosis pathway linking altered microbial tryptophan metabolism to impaired osteogenesis. They provide a rationale for evaluating IPA as a potential therapeutic strategy for diabetic osteoporosis.
- Open Access
- 17 July 2026
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 21 (1)
Internal brace augmentation versus modified brostrom-gould procedure for chronic lateral ankle instability: a systematic review and meta-analysis of functional and radiographic outcomes
To compare functional, radiographic, and safety outcomes between internal brace (IB) augmentation and modified Broström-Gould (MBG) repair for chronic
- 17 July 2026
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 21 (1)
Open AccessInternal brace augmentation versus modified brostrom-gould procedure for chronic lateral ankle instability: a systematic review and meta-analysis of functional and radiographic outcomes
To compare functional, radiographic, and safety outcomes between internal brace (IB) augmentation and modified Broström-Gould (MBG) repair for chronic
- 20 June 2026
- Published by Springer Nature in European Spine Journal
- Vol. 35 (9) , 1-17
Development of a predictive model for postoperative erectile function recovery in male patients with incomplete traumatic cervical spinal cord injury
Background Erectile dysfunction (ED) is prevalent after traumatic cervical spinal cord injury (CSCI), yet predictive tools for postoperative recovery remain underdeveloped. This study aimed to develop a clinical prediction model for erectile function recovery in male patients undergoing posterior cervical surgery for incomplete traumatic CSCI (iCSCI). Methods In this retrospective cohort study, 207 male patients (aged 18–60 years) with iCSCI (ASIA grades B–D) who underwent posterior cervical decompression between 2018 and 2023 were included. Erectile function was assessed using the International Index of Erectile Function-5 (IIEF-5) at protocol-defined 3-month and 2-year postoperative follow-up visits. Improvement was defined as an increase of ≥ 1 severity category. Candidate predictors were screened via univariate analysis (P ≤ 0.20) and correlation assessment, followed by forward stepwise logistic regression. Model performance was evaluated using area under the receiver operating characteristic (ROC) curve (AUC) and internally validated via bootstrapping. Results Median total follow-up was 41.00 months. Overall, 72.5% of patients showed erectile function improvement. The final prediction model included four independent predictors: preoperative ASIA grade (OR for grade D vs. B: 30.519, P < 0.001), injury level (C0–C3 vs. C4–C7; OR: 5.749, P = 0.012), injury to surgery interval (OR per day: 0.858, P = 0.018), and spinal cord compression ratio (OR per 1%: 0.937, P = 0.002). The model demonstrated robust discrimination (AUC: 0.881) and good calibration (Hosmer–Lemeshow P = 0.194). Bootstrap internal validation yielded an optimism-corrected AUC of 0.850. A nomogram was constructed to facilitate individualized risk estimation. Conclusion In male iCSCI patients, erectile function demonstrates significant potential for recovery following posterior cervical surgery. The validated four-factor model—presented as a clinical nomogram—enables personalized preoperative risk stratification to guide counseling and rehabilitation planning. External validation is required before widespread clinical implementation.
- 20 June 2026
- Published by Springer Nature in European Spine Journal
- Vol. 35 (9) , 1-17
Development of a predictive model for postoperative erectile function recovery in male patients with incomplete traumatic cervical spinal cord injury
Background Erectile dysfunction (ED) is prevalent after traumatic cervical spinal cord injury (CSCI), yet predictive tools for postoperative recovery remain underdeveloped. This study aimed to develop a clinical prediction model for erectile function recovery in male patients undergoing posterior cervical surgery for incomplete traumatic CSCI (iCSCI). Methods In this retrospective cohort study, 207 male patients (aged 18–60 years) with iCSCI (ASIA grades B–D) who underwent posterior cervical decompression between 2018 and 2023 were included. Erectile function was assessed using the International Index of Erectile Function-5 (IIEF-5) at protocol-defined 3-month and 2-year postoperative follow-up visits. Improvement was defined as an increase of ≥ 1 severity category. Candidate predictors were screened via univariate analysis (P ≤ 0.20) and correlation assessment, followed by forward stepwise logistic regression. Model performance was evaluated using area under the receiver operating characteristic (ROC) curve (AUC) and internally validated via bootstrapping. Results Median total follow-up was 41.00 months. Overall, 72.5% of patients showed erectile function improvement. The final prediction model included four independent predictors: preoperative ASIA grade (OR for grade D vs. B: 30.519, P < 0.001), injury level (C0–C3 vs. C4–C7; OR: 5.749, P = 0.012), injury to surgery interval (OR per day: 0.858, P = 0.018), and spinal cord compression ratio (OR per 1%: 0.937, P = 0.002). The model demonstrated robust discrimination (AUC: 0.881) and good calibration (Hosmer–Lemeshow P = 0.194). Bootstrap internal validation yielded an optimism-corrected AUC of 0.850. A nomogram was constructed to facilitate individualized risk estimation. Conclusion In male iCSCI patients, erectile function demonstrates significant potential for recovery following posterior cervical surgery. The validated four-factor model—presented as a clinical nomogram—enables personalized preoperative risk stratification to guide counseling and rehabilitation planning. External validation is required before widespread clinical implementation.
- Open Access
- 3 June 2026
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 58 (2) , 1-15
Microbiota‑derived indole‑3‑propionic acid reprograms bone marrow stem cell fate via PPARγ suppression to rescue osteoporosis
Osteoporosis (OP) is increasingly recognised as a disorder driven by impaired lineage allocation of bone marrow stromal cells (BMSCs), characterised by a shift from osteogenesis toward adipogenesis under conditions such as oestrogen deficiency and oxidative stress. Although gut microbiota‑derived metabolites have emerged as critical regulators of skeletal homeostasis, their direct role in BMSC fate determination remains poorly understood. In the present study, indole‑3‑propionic acid (IPA) was identified, a metabolite produced by Clostridium sporogenes, as a key regulator of bone‑fat balance. Integrative analyses combining 16S rRNA sequencing, metabolomics, transcriptomics and functional assays revealed that IPA levels were significantly reduced in ovariectomised mice and positively correlated with bone mass. Functionally, IPA protected BMSCs from oxidative stress‑induced apoptosis, restored osteogenic capacity, and suppressed adipogenic differentiation. Mechanistically, RNA sequencing and molecular docking analyses demonstrated that IPA modulates the peroxisome proliferator‑activated receptor gamma (PPARγ) signalling pathway, thereby reprogramming BMSC lineage commitment. In vivo, oral administration of IPA markedly improved trabecular bone microarchitecture, enhanced bone formation, and corrected marrow adiposity without detectable systemic toxicity. Collectively, the present findings identified IPA as a previously under‑recognised microbiota‑derived metabolite that maintains skeletal homeostasis by restoring the osteogenic‑adipogenic balance through suppression of PPARγ signalling. The present study uncovers a mechanistic link between gut microbial metabolism and BMSC fate regulation and highlights IPA as a promising therapeutic candidate for OP.
- 3 June 2026
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 58 (2) , 1-15
Open AccessMicrobiota‑derived indole‑3‑propionic acid reprograms bone marrow stem cell fate via PPARγ suppression to rescue osteoporosis
Osteoporosis (OP) is increasingly recognised as a disorder driven by impaired lineage allocation of bone marrow stromal cells (BMSCs), characterised by a shift from osteogenesis toward adipogenesis under conditions such as oestrogen deficiency and oxidative stress. Although gut microbiota‑derived metabolites have emerged as critical regulators of skeletal homeostasis, their direct role in BMSC fate determination remains poorly understood. In the present study, indole‑3‑propionic acid (IPA) was identified, a metabolite produced by Clostridium sporogenes, as a key regulator of bone‑fat balance. Integrative analyses combining 16S rRNA sequencing, metabolomics, transcriptomics and functional assays revealed that IPA levels were significantly reduced in ovariectomised mice and positively correlated with bone mass. Functionally, IPA protected BMSCs from oxidative stress‑induced apoptosis, restored osteogenic capacity, and suppressed adipogenic differentiation. Mechanistically, RNA sequencing and molecular docking analyses demonstrated that IPA modulates the peroxisome proliferator‑activated receptor gamma (PPARγ) signalling pathway, thereby reprogramming BMSC lineage commitment. In vivo, oral administration of IPA markedly improved trabecular bone microarchitecture, enhanced bone formation, and corrected marrow adiposity without detectable systemic toxicity. Collectively, the present findings identified IPA as a previously under‑recognised microbiota‑derived metabolite that maintains skeletal homeostasis by restoring the osteogenic‑adipogenic balance through suppression of PPARγ signalling. The present study uncovers a mechanistic link between gut microbial metabolism and BMSC fate regulation and highlights IPA as a promising therapeutic candidate for OP.
- Open Access
- 27 April 2026
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 21 (1) , 279
Comparative analysis of different mobility aids in the early accelerated rehabilitation phase following acute achilles tendon repair surgery: a prospective cohort study
Background: The objective of this study was to evaluate and compare the safety, efficacy, and cost-effectiveness of different mobility aids during the early rehabilitation phase following surgical repair of acute Achilles tendon rupture (AATR). Methods: This prospective cohort study included 198 patients who underwent surgical repair for AATR between April 2023 and February 2025, with 171 males (86.4%) and a mean age of 36.4 years. Based on the mobility aid used weeks 3–6 postoperatively, participants were categorized into four groups: Wheelchair ( n = 43), Knee Scooter ( n = 41), Axillary Crutches ( n = 78), and Leg Support (LS) Walker ( n = 36). Patients were scheduled for assessments at 2, 4, 6, 12, and 24 weeks, with an additional telephone follow-up conducted approximately one year after surgery. Primary outcomes included the rate of unplanned Emergency Department (ED) visits, the affected-to-unaffected (A: U) calf circumference ratio, and expected rehabilitation costs. Secondary outcomes encompassed the Visual Analog Scale, the Achilles Tendon Total Rupture Score, the American Orthopedic Foot & Ankle Society Ankle-Hindfoot Score, and time to key recovery milestones, including single-leg heel raise to 50% of contralateral side, return to light exercise, return to work, and return to pre-injury exercise. Continuous variables were analyzed using one-way ANOVA or Kruskal-Wallis test, and categorical variables using chi-square or Fisher’s exact test, while linear mixed-effects models were employed for longitudinal outcomes. Results: During the early rehabilitation phase (Weeks 3–6), unplanned ED visit rates differed significantly among the four groups ( p = 0.032), with the Axillary Crutches showing significantly higher odds than the Wheelchair (OR = 8.24, 95% CI 1.16–58.53, p = 0.040). A significant difference in the A: U ratio was observed among the four groups at 6 weeks postoperatively ( p = 0.037), and post-hoc comparisons showed significant differences for LS Walker vs. Wheelchair ( p < 0.001), Axillary Crutches vs. Wheelchair ( p = 0.002), and LS Walker vs. Knee Scooter ( p = 0.038). The LS Walker and Axillary Crutches also demonstrated superior performance in VAS, ATRS, and AOFAS scores from Week 4 to Week 12, and achieved key recovery milestones significantly earlier ( p < 0.001). Economic analysis revealed the lower direct treatment costs in the Axillary Crutches (477 RMB) and Knee Scooter (539 RMB), followed by the Wheelchair (664 RMB) and LS Walker (1126 RMB) ( p < 0.001). Conclusions: LS Walker demonstrated superior efficacy in preserving muscle and accelerating functional recovery, while Knee Scooter offered a favorable profile for fall prevention and cost-effectiveness. Trial registration: ClinicalTrials.gov (NCT04663542), registered on 22 September 2020.
- 27 April 2026
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 21 (1) , 279
Open AccessComparative analysis of different mobility aids in the early accelerated rehabilitation phase following acute achilles tendon repair surgery: a prospective cohort study
Background: The objective of this study was to evaluate and compare the safety, efficacy, and cost-effectiveness of different mobility aids during the early rehabilitation phase following surgical repair of acute Achilles tendon rupture (AATR). Methods: This prospective cohort study included 198 patients who underwent surgical repair for AATR between April 2023 and February 2025, with 171 males (86.4%) and a mean age of 36.4 years. Based on the mobility aid used weeks 3–6 postoperatively, participants were categorized into four groups: Wheelchair ( n = 43), Knee Scooter ( n = 41), Axillary Crutches ( n = 78), and Leg Support (LS) Walker ( n = 36). Patients were scheduled for assessments at 2, 4, 6, 12, and 24 weeks, with an additional telephone follow-up conducted approximately one year after surgery. Primary outcomes included the rate of unplanned Emergency Department (ED) visits, the affected-to-unaffected (A: U) calf circumference ratio, and expected rehabilitation costs. Secondary outcomes encompassed the Visual Analog Scale, the Achilles Tendon Total Rupture Score, the American Orthopedic Foot & Ankle Society Ankle-Hindfoot Score, and time to key recovery milestones, including single-leg heel raise to 50% of contralateral side, return to light exercise, return to work, and return to pre-injury exercise. Continuous variables were analyzed using one-way ANOVA or Kruskal-Wallis test, and categorical variables using chi-square or Fisher’s exact test, while linear mixed-effects models were employed for longitudinal outcomes. Results: During the early rehabilitation phase (Weeks 3–6), unplanned ED visit rates differed significantly among the four groups ( p = 0.032), with the Axillary Crutches showing significantly higher odds than the Wheelchair (OR = 8.24, 95% CI 1.16–58.53, p = 0.040). A significant difference in the A: U ratio was observed among the four groups at 6 weeks postoperatively ( p = 0.037), and post-hoc comparisons showed significant differences for LS Walker vs. Wheelchair ( p < 0.001), Axillary Crutches vs. Wheelchair ( p = 0.002), and LS Walker vs. Knee Scooter ( p = 0.038). The LS Walker and Axillary Crutches also demonstrated superior performance in VAS, ATRS, and AOFAS scores from Week 4 to Week 12, and achieved key recovery milestones significantly earlier ( p < 0.001). Economic analysis revealed the lower direct treatment costs in the Axillary Crutches (477 RMB) and Knee Scooter (539 RMB), followed by the Wheelchair (664 RMB) and LS Walker (1126 RMB) ( p < 0.001). Conclusions: LS Walker demonstrated superior efficacy in preserving muscle and accelerating functional recovery, while Knee Scooter offered a favorable profile for fall prevention and cost-effectiveness. Trial registration: ClinicalTrials.gov (NCT04663542), registered on 22 September 2020.
- 13 April 2026
- Published by Springer Nature in European Spine Journal
- Vol. 35 (8) , 5105-5119
Modified anterior long-segment fixation versus posterior and combined approaches for subaxial cervical fractures in ankylosing spondylitis: a retrospective cohort study
- 13 April 2026
- Published by Springer Nature in European Spine Journal
- Vol. 35 (8) , 5105-5119
Modified anterior long-segment fixation versus posterior and combined approaches for subaxial cervical fractures in ankylosing spondylitis: a retrospective cohort study